Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to.

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

Women over 50 face increased eye health risks post-menopause due to hormonal shifts. Conditions like dry eye, cataracts, glaucoma, and age-related macular degeneration become more prevalent.

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

Dry eyes are also a common source of itch - the result of hormonal changes related to aging, taking certain medications, some autoimmune diseases like rheumatoid arthritis, and staring at screens ...

Used the gel for dry eyelids. Twice a day for the first few days, now once a day. Completely cleared up with a couple of ...

An eye cream could make all the difference. Experts share exactly what to consider and how to find the right one.

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...

It’s like a drink of water for my under-eyes.

This ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global ...

Aldeyra plans to request a Type A meeting and currently does not intend further clinical trials, asserting rapid-onset activity within minutes versus existing therapies requiring weeks to months.